Hexedrone: Difference between revisions
>Unity Changed distinguish tag to make the designer drug relationship more apparent. |
>Unity Removed headerpanel, implemented new SubstanceSheet. |
||
| Line 1: | Line 1: | ||
{{distinguish2|[[N-Ethylhexedrone|N-Ethylhexedrone (Hexen)]]}} | {{distinguish2|[[N-Ethylhexedrone|N-Ethylhexedrone (Hexen)]]}} | ||
{{SubstanceBox/Hexedrone}} | {{SubstanceBox/Hexedrone}} | ||
{ | {{SummarySheet}} | ||
'''Hexedrone''' is a novel synthetic [[psychoactive class::stimulant]] of the [[chemical category::cathinone]] chemical class that produces [[stimulation]], [[disinhibition]], [[thought acceleration]] and [[euphoria]] when [[Routes of administration|administered]]. Considering the close structurally similarities it share with [[pentedrone]], it has been speculated to act as a [[norepinephrine]]-[[dopamine]]-[[reuptake inhibitor|reuptake-inhibitor]] (NDRI). However, this has yet to be scientifically validated. | |||
'''Hexedrone''' is a [[ | |||
Due to | Little research exists about both hexedrone, particularly with regards to its toxicity, addiction, and abuse potential. Due to its novelty and extremely short history of human usage, all information related to the use of this compound should be treated with extreme caution. | ||
==Chemistry== | ==Chemistry== | ||
| Line 60: | Line 55: | ||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
{{Further|Research chemicals#Toxicity and harm potential}} | {{Further|Research chemicals#Toxicity and harm potential}} | ||
Since hexedrone has been insufficiently studied and most data consists of speculation and user experiences, one should be cautious when it comes to the risks and harm | Since hexedrone has been insufficiently studied and most data consists of speculation and user experiences, one should be especially cautious when it comes to the risks and harm this substance may pose, especially in terms of seriouslong-term health hazards. | ||
It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this drug. | It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this drug. | ||
===Tolerance and addiction potential=== | ===Tolerance and addiction potential=== | ||
As with other [[stimulant]]s, the chronic use of Hexedrone can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage. | As with other [[stimulant]]s, the chronic use of Hexedrone can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage. | ||
Tolerance to many of the effects of | Tolerance to many of the effects of hexedrone [[Time to full tolerance::develops with prolonged and repeated use]]. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about [[Time to half tolerance::3 - 7 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::1 - 2 weeks]] to be back at baseline (in the absence of further consumption). Hexedrone presents cross-tolerance with [[Cross-tolerance::all [[dopamine]]rgic [[stimulant]]s]], meaning that after the consumption of Hexedrone all [[stimulant]]s will have a reduced effect. | ||
==Legal issues== | ==Legal issues== | ||
| Line 75: | Line 70: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Research chemical]] | |||
*[[Stimulant]] | *[[Stimulant]] | ||
*[[Substituted cathinone | *[[Substituted cathinone]] | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/Hexedrone Hexedrone (Wikipedia)] | *[https://en.wikipedia.org/wiki/Hexedrone Hexedrone (Wikipedia)] | ||
Revision as of 21:29, 11 May 2017
| Hexedrone | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||
| Common names | Hexedrone | ||||||||||||||||||||||||||
| Systematic name | 2-(methylamino)-1-phenylhexan-1-one | ||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||
| Psychoactive class | Stimulant | ||||||||||||||||||||||||||
| Chemical class | Cathinone | ||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
| Interactions | |||||||||||||||||||||||||||
| Summary sheet: Hexedrone |
Hexedrone is a novel synthetic stimulant of the cathinone chemical class that produces stimulation, disinhibition, thought acceleration and euphoria when administered. Considering the close structurally similarities it share with pentedrone, it has been speculated to act as a norepinephrine-dopamine-reuptake-inhibitor (NDRI). However, this has yet to be scientifically validated.
Little research exists about both hexedrone, particularly with regards to its toxicity, addiction, and abuse potential. Due to its novelty and extremely short history of human usage, all information related to the use of this compound should be treated with extreme caution.
Chemistry
Hexedrone is a cathinone, which is closely related to amphetamines, but have a ß-substituted ketone group as well. Relative to regular cathinone, which can be found in the Khat plant, hexedrone consists of two added substitutions. At the R2 position, a n-Butyl substitution forms a hexan chain. The second substitution is a Methyl group, that's attached to the amine (R4), thus forming N-Methyl.
Pharmacology
Due to the lack of research regarding the substance, all discussion regarding the pharmacology of it is purely based upon its structure and subjective effect similarities to other cathinones such as pentedrone and others. Hexedrone most likely acts as both a dopamine and norepinephrine reuptake inhibitor. This allows dopamine and norepinephrine to build up within the brain, resulting in stimulating and euphoric effects.
The decreased potency, compared to both pentedrone as well as ethyl-hexedrone can be easily explained. Compared to pentedrone, there's a larger non-polar side chain. Ethyl-hexedrone has an ethyl group, instead of a methyl, which results in a significantly shifted electronegativity.
Subjective effects
Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.
It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.
Physical effects
- Spontaneous tactile sensations - High doses of hexedrone result in a pleasurable body high characterized by pleasant tingling.
- Stimulation - In terms of its effects on the user's physical energy levels, hexedrone can be considered to be extremely stimulating and energetic.
- Dehydration - Dry mouth and increased sweating can occur after consuming hexedrone. Low doses of the substance in question cause minimal dehydration.
- Vasoconstriction - Hexedrone can be considered slightly vasoconstricting.
- Tactile enhancement
- Increased heart rate
- Increased perspiration
- Appetite suppression
- Focus enhancement
- Temporary erectile dysfunction
- Increased blood pressure
- Teeth grinding - This component can be considered to be less intense when compared with that of MDMA.
Cognitive effects
- Euphoria
- Thought acceleration
- Analysis enhancement - This effect is mostly present in lower doses when not overshadowed by euphoria.
- Immersion enhancement
- Time distortion
- Ego inflation
- Disinhibition
- Motivation enhancement
- Compulsive redosing
- Increased music appreciation
After effects
The effects which occur during the offset of a stimulant experience generally feel negative and uncomfortable in comparison to the effects which occurred during its peak. This is often referred to as a "comedown" and occurs because of neurotransmitter depletion. Its effects commonly include:
- Anxiety
- Cognitive fatigue
- Depression
- Irritability
- Motivation suppression
- Thought deceleration
- Wakefulness
Toxicity and harm potential
Since hexedrone has been insufficiently studied and most data consists of speculation and user experiences, one should be especially cautious when it comes to the risks and harm this substance may pose, especially in terms of seriouslong-term health hazards.
It is strongly recommended that one use harm reduction practices when using this drug.
Tolerance and addiction potential
As with other stimulants, the chronic use of Hexedrone can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage.
Tolerance to many of the effects of hexedrone develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). Hexedrone presents cross-tolerance with [[Cross-tolerance::all dopaminergic stimulants]], meaning that after the consumption of Hexedrone all stimulants will have a reduced effect.
Legal issues
 |
This legality section is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it. |
- UK - In the UK, Hexedrone is a Class B drug under The Misuse of Drugs Act 1971 (Amendment) Order 2010 following the ACMD's report on substituted cathinone derivatives,[1] making it illegal to sell, buy, or possess without a license.[2][3]
See also
External links
References
- ↑ https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/119173/acmd-cathinodes-report-2010.pdf
- ↑ http://webarchive.nationalarchives.gov.uk/20130125102358/http://www.homeoffice.gov.uk/about-us/corporate-publications-strategy/home-office-circulars/circulars-2010/010-2010/
- ↑ http://www.legislation.gov.uk/uksi/2010/1207/article/2/made